March 22, 2024
JPMA Director General Kenshi Kinoshita (right), Senior Managing Director Kazuhiko Mori The Japan Pharmaceutical Manufacturers Association (JPMA) looks set to step up its efforts to lobby against “off-year” drug price revisions towards FY2025, arguing that it stifles innovation and cripples...read more